J&J Celebrates Simponi Approval With Schering – For Now
As Schering waits to see if partner J&J will challenge Merck merger, FDA clears once-monthly follow-on to Remicade.
As Schering waits to see if partner J&J will challenge Merck merger, FDA clears once-monthly follow-on to Remicade.